Effect of sofosbuvir and daclatasvir treatment on the blood indices in patients with chronic hepatitis C virus
Hematological problems often occur in HCV patients both before and after SOF and DCV treatment. Treatment failure was associated with the presence of one or more baseline cytopenias, as well as the development of anemia during treatment. Nonetheless, SOF and DCV are still safe to be used in the presence of cytopenia.
Authors
- Mohamed Hassany
- Wael Abdel‐Razek (ORCID: https://orcid.org/0000-0003-0114-798X)
- Wafaa Elakel (ORCID: https://orcid.org/0000-0002-0055-2230)
- Rabab Fouad (ORCID: https://orcid.org/0000-0001-8975-7920)
- Wahid Doss
- Mohamed Fateen (ORCID: https://orcid.org/0000-0002-1533-4092)
- Hesham Elmakhzangy (ORCID: https://orcid.org/0000-0001-8595-0061)
- Mirella Sherif
- Rania Lithy
Institutions
- Cairo University (EG)
- National Water Research Center (EG)
- Menoufia University (EG)
Publication Details
- Journal
- Arab Journal of Gastroenterology
- Published
- 2025-01-27
- DOI
- https://doi.org/10.1016/j.ajg.2024.11.004
- Primary Topic
- Hepatitis C virus research
- Type
- article
- Field-Weighted Citation Impact
- 0.00